Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL-BP 2
KCT0011595Phase 3Not yet recruiting
- Sponsor
- Yonsei University Health System
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of phenylephrine in ischemic stroke, sponsored by Yonsei University Health System. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
phenylephrine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on KCT0011595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011595.